These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 16739311)
1. SMAD4/DPC4 expression and prognosis in human colorectal cancer. Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311 [TBL] [Abstract][Full Text] [Related]
2. Expression of Smad4 and TGF-beta2 in colorectal carcinoma. Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611 [TBL] [Abstract][Full Text] [Related]
3. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510 [TBL] [Abstract][Full Text] [Related]
4. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma. Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212 [TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma. Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018 [TBL] [Abstract][Full Text] [Related]
6. SMAD4 as a prognostic marker in colorectal cancer. Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640 [TBL] [Abstract][Full Text] [Related]
7. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome. Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972 [TBL] [Abstract][Full Text] [Related]
8. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274 [TBL] [Abstract][Full Text] [Related]
9. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360 [TBL] [Abstract][Full Text] [Related]
10. Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma. Hiwatashi K; Ueno S; Sakoda M; Kubo F; Tateno T; Kurahara H; Mataki Y; Maemura K; Ishigami S; Shinchi H; Natsugoe S Ann Surg Oncol; 2009 Nov; 16(11):3176-82. PubMed ID: 19626374 [TBL] [Abstract][Full Text] [Related]
11. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification. Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
13. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer. Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263 [TBL] [Abstract][Full Text] [Related]
15. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer]. Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784 [TBL] [Abstract][Full Text] [Related]
16. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer]. Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060 [TBL] [Abstract][Full Text] [Related]
17. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis. Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes. Baker K; Chong G; Foulkes WD; Jass JR Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200 [TBL] [Abstract][Full Text] [Related]